BSE Live
Oct 01, 16:01Prev. Close
129.30
Open Price
131.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 01, 15:57Prev. Close
129.52
Open Price
130.04
Bid Price (Qty.)
132.15 (1117)
Offer Price (Qty.)
0.00 (0)
Cash Flow of Sun Pharma Advanced Research Company (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | |
12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | -342.78 | -386.83 | -222.58 | |
Net CashFlow From Operating Activities | -360.29 | -429.19 | -69.12 | |
Net Cash Used In Investing Activities | 157.66 | 391.53 | -548.28 | |
Net Cash Used From Financing Activities | 199.26 | 42.41 | 616.76 | |
Foreign Exchange Gains / Losses | 0.01 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | -3.37 | 4.75 | -0.64 | |
Cash And Cash Equivalents Begin of Year | 5.33 | 0.58 | 1.22 | |
Cash And Cash Equivalents End Of Year | 1.96 | 5.33 | 0.58 |
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
20.05.2025
Sun Pharma Adv Consolidated March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y
20.05.2025
Sun Pharma Adv Standalone March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
20.05.2025
Sun Pharma Adv Consolidated March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y
20.05.2025
Sun Pharma Adv Standalone March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y